Whole Exome Sequencing Identifies FBN1 Mutations in Two Patients with Early-Onset Type B Aortic Dissection

Qian Han,Wenwen Zhang,Changjian Liu,Min Zhou,Feng Ran,Long Yi,Xitai Sun,Zhao Liu
DOI: https://doi.org/10.3892/mmr.2017.7410
IF: 3.423
2017-01-01
Molecular Medicine Reports
Abstract:The etiology of thoracic aortic aneurysm and dissection (TAAD) is complex and heterogeneous. Emerging evidence has demonstrated that genetic causes may be a consideration in early-onset TAAD. Owing to overlapping clinical phenotypes and the genetic heterogeneity of TAAD, it is challenging for clinicians to make a molecular diagnosis of TAAD, particularly in those who present with non-specific syndromic features. In order to identify the causative mutation in two young patients with acute type B aortic dissection without syndromic features, whole exome sequencing (WES) was performed in the present study. A missense mutation (c.G6953A:p.C2318Y) and a nonsense mutation (c.C4786T:p.R1596X) were identified in the fibrillin 1 gene in patients T287 and T267, respectively. The present study emphasized the necessity of genetic testing for young patients with type B aortic dissection. WES is a timely, robust and inexpensive technique for molecular diagnosis, particularly for TAAD caused by numerous genes. Genetic diagnosis of Marfan syndrome could aid in periodic surveillance, prophylactic surgical measures, and genetic counseling.
What problem does this paper attempt to address?